mice-contact

Alan Wake 2, Remedy's gorgeous oddity, is finally making the developer some cash, over a year after its launch. In a published today, the Finnish studio revealed that sales of the sequel had now surpassed two million units, and that "the game started to accrue royalties".

It's taken a while—Alan Wake 2 launched in October 2023, and only started turning a profit at the end of 2024, according to the financial report. With a huge development and marketing (reportedly €70 million/$73 million), there was a lot to recoup before it could start earning Remedy some cash. And while it was Remedy's fastest-selling game, and two million sales in just over a year isn't to be sniffed at, Alan Wake isn't the kinda heavy-hitter in the horror genre that, say, Silent Hill is. Bloober's Silent Hill 2 remake, for instance, hit that same 2 million sales milestone in January, only a few months after launch.

Remedy hasn't exactly been struggling while it's been waiting for Alan to make some money, though. In February last year, it from publisher 505 Games in a €17 million/$17.7 million deal. Then, in August, it announced it would be , with assistance from Annapurna Pictures.

Annapurna is financing 50% of the game's development budget, and it got the rights to develop Control and Alan Wake TV shows and films. Soon after this announcement, Annapurna Interactive, the videogame division of the company, , with all staff quitting. This, however, apparently doesn't affect the deal with Remedy, since Annapurna Pictures was not affected by the collapse of the videogame team. Still, it's probably [[link]] not a positive [[link]] thing.

In September, Remedy and Tencent also entered into a which could eventually be converted into Remedy shares after three years, netting the Chinese conglomerate an even greater stake in the company. It already controls 14% of Remedy, and these shares would amount to around 5.8% of Remedy. The deal was up for discussion in Remedy's Extraordinary General Meeting in October, where shareholders approved the loan.

Remedy had previously worked with Tencent on Project Kestral (previously codenamed Vanguard), a free-to-play co-op live service affair. It was officially last year, and it seems like Remedy took a bit of a hit from that one. While its operating profit had improved by €11.4 million in the fourth quarter of 2024 (which puts it at -€1.4 million) [[link]] it lost €7.2 million in value the previous year due to Kestral.

Things are presumably looking up, now, though. It's got that Tencent cash, Alan's bringing in some money at last, and it's got a few projects on the go, including Control 2. In October, it announced co-op FPS Control spin-off (which had previously been teased under the codename Condor) and the , which are "making steady progress in full production", according to the financial report.